Bottom line
MSVEX vs BKUI: the short answer
MSVEX (Vitality Portfolio) and BKUI (BNY Mellon Ultra Short Income ETF) are both mutual funds.
BKUI is cheaper at 0.12% vs 1.3% — a difference of $118 a year per $10,000 invested.
Over one year, MSVEX returned +8.7% vs +5.0% for BKUI.
MSVEX has a front-end sales load of up to 5.25%; the other does not.
Updated Nov 19, 2026
MSVEX vs BKUI side by side
| MSVEX | BKUI | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Morgan Stanley | BNY Mellon / Dreyfus |
| Category | Other | Other |
| Expense ratio | 1.3% | 0.12% |
| Annual cost per $10k | $130 | $12 |
| 10-yr cost on $10k (prospectus) | $10,017 | $154 |
| Max front load | 5.25% | None |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +8.7% | +5.0% |
| 5-yr return (annualized) | — | — |
| 10-yr return (annualized) | — | — |
| Best quarter | — | +2.0% |
| Worst quarter | — | −1.0% |
| Net assets (fund) | — | $574.7M |
| Number of holdings | — | 157 |
| Portfolio turnover | 27% | 14% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
MSVEX and BKUI share none of their top holdings.
MSVEX top 10
BKUI top 10
- Dnb Bank Asa — 2.86%
- Credit Industriel Et Commercial-cic Sa New York Branch — 2.61%
- Banco Santander Sa — 2.52%
- Norddeutsche Lan 0627 — 2.51%
- Societe Generale North America Inc — 2.14%
- Banco Bilbao Vizcaya Argentaria Sa — 2.10%
- Westpac Banking Corp — 2.10%
- Abn Amro Funding USA Llc — 2.07%
- Old Line Funding LLC — 2.05%
- Manhattan Asset Funding Company LLC — 1.74%
FAQ
What is the difference between MSVEX and BKUI?
MSVEX (Vitality Portfolio) and BKUI (BNY Mellon Ultra Short Income ETF) are both mutual funds. BKUI is cheaper at 0.12% vs 1.3% — a difference of $118 a year per $10,000 invested.
Which is cheaper, MSVEX or BKUI?
BKUI has the lower expense ratio (0.12%).
Should I own both MSVEX and BKUI?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.